Dataset
Amprenavir
Chemical Info
InChI | InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1 |
---|---|
SMILES | CC(C)CN(CC(O)C(NC(=O)OC(C3)COC3)Cc(c2)cccc2)S(=O)(=O)c(c1)ccc(N)c1 |
InChI Key | YMARZQAQMVYCKC-OEMFJLHTSA-N |
Molecular Formula | C25H35N3O6S |
Exact Mass | 505.225 g/mol |
Data and Resources
Metadata Information
Field | Value |
---|---|
DOI | |
License URL | https://creativecommons.org/licenses/by-nc/4.0 |
Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA001168 |
Version | |
Author | |
Maintainer | |
Language | |
MetadataCreated | 2024-01-11T22:47:52.633701 |
MetadataModified | 2024-01-11T22:47:52.804067 |
MetadataPublished | 2016-01-19 |
Field | Value |
---|---|
Measurement Technique | liquid chromatography-mass spectrometry |
Measurement Variables |
Data-Source Molecule ID | Data-Source |
---|---|
Amprenavir-(Agenerase) | Selleck |
PD010072 | ProbesDrugs |
5S0W860XNR | FDA SRS |
14835820 | PubChem: Thomson Pharma |
14884574 | PubChem: Thomson Pharma |
65016 | PubChem |
SCHEMBL34151 | SureChEMBL |
J1.015.291G | Nikkaji |
40050 | ChEBI |
MCULE-8147835017 | Mcule |
200 | DrugCentral |
ZINC000003809192 | ZINC |
577 | BindingDB |
AMPRENAVIR | DailyMed |
229161 | Brenda |
229162 | Brenda |
HY-17430 | MedChemExpress |
KVX-478 | clinicaltrials |
AGENERASE | clinicaltrials |
141W94 | clinicaltrials |
AMPRENAVIR | clinicaltrials |
VX-478 | clinicaltrials |
141 W94 | clinicaltrials |
AMPRENAVIR | rxnorm |
1608 | Brenda |
50215393 | BindingDB |
CB4186139 | ChemicalBook |
HMDB0014839 | Human Metabolome Database |
PA448422 | PharmGKB |
DB00701 | DrugBank |
C08086 | KEGG Ligand |
CHEMBL116 | ChEMBL |
478 | PDBe |
12014852 | PubChem: Drugs of the Future |
877446 | eMolecules |
The data in this table is sourced from UniChem at EBI. |